<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McCrary MR</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>American Heart Association</funding><funding>RRD VA</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>10680-10691</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6766648</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(10)</volume><pubmed_abstract>GPCR 37 (GPR37) is a GPCR expressed in the CNS; its physiological and pathophysiological functions are largely unknown. We tested the role of GPR37 in the ischemic brain of GPR37 knockout (KO) mice, exploring the idea that GPR37 might be protective against ischemic damage. In an ischemic stroke model, GPR37 KO mice exhibited increased infarction and cell death compared with wild-type (WT) mice, measured by 2,3,5-triphenyl-2H-tetrazolium chloride and TUNEL staining 24 h after stroke. Moreover, more severe functional deficits were detected in GPR37 KO mice in the adhesive-removal and corner tests. In the peri-infarct region of GPR37 KO mice, there was significantly more apoptotic and autophagic cell death accompanied by caspase-3 activation and attenuated mechanistic target of rapamycin sign</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>Protective effects of GPR37 &lt;i>via&lt;/i> regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.</pubmed_title><pmcid>PMC6766648</pmcid><funding_grant_id>R01 NS085568</funding_grant_id><funding_grant_id>NS073378</funding_grant_id><funding_grant_id>R01 NS088413</funding_grant_id><funding_grant_id>R44 NS073378</funding_grant_id><funding_grant_id>I01 RX000666</funding_grant_id><funding_grant_id>NS091585</funding_grant_id><funding_grant_id>NS088413</funding_grant_id><funding_grant_id>R42 NS073378</funding_grant_id><funding_grant_id>R01 NS091585</funding_grant_id><funding_grant_id>T32 GM008169</funding_grant_id><funding_grant_id>NS085568</funding_grant_id><funding_grant_id>POST25710112</funding_grant_id><funding_grant_id>R41 NS073378</funding_grant_id><pubmed_authors>Wei ZZ</pubmed_authors><pubmed_authors>Jiang MQ</pubmed_authors><pubmed_authors>Gu X</pubmed_authors><pubmed_authors>McCrary MR</pubmed_authors><pubmed_authors>Zhang JY</pubmed_authors><pubmed_authors>Giddens MM</pubmed_authors><pubmed_authors>Zhong W</pubmed_authors><pubmed_authors>Yu SP</pubmed_authors><pubmed_authors>Xin H</pubmed_authors><pubmed_authors>Hall RA</pubmed_authors><pubmed_authors>Owino S</pubmed_authors><pubmed_authors>Wei L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protective effects of GPR37 &lt;i>via&lt;/i> regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.</name><description>GPCR 37 (GPR37) is a GPCR expressed in the CNS; its physiological and pathophysiological functions are largely unknown. We tested the role of GPR37 in the ischemic brain of GPR37 knockout (KO) mice, exploring the idea that GPR37 might be protective against ischemic damage. In an ischemic stroke model, GPR37 KO mice exhibited increased infarction and cell death compared with wild-type (WT) mice, measured by 2,3,5-triphenyl-2H-tetrazolium chloride and TUNEL staining 24 h after stroke. Moreover, more severe functional deficits were detected in GPR37 KO mice in the adhesive-removal and corner tests. In the peri-infarct region of GPR37 KO mice, there was significantly more apoptotic and autophagic cell death accompanied by caspase-3 activation and attenuated mechanistic target of rapamycin sign</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2026-06-04T00:58:39.373Z</modification><creation>2020-07-06T07:04:12Z</creation></dates><accession>S-EPMC6766648</accession><cross_references><pubmed>31268736</pubmed><doi>10.1096/fj.201900070R</doi><doi>10.1096/fj.201900070r</doi></cross_references></HashMap>